Mexican officials said Tuesday they are beginning deployment of the country’s new National Guard for immigration enforcement, an accelerated commitment of a 6,000-strong force made as part of an agreement with the United States to head off threatened U.S. tariffs on imports from Mexico.
President Andrés Manuel López Obrador and Foreign Relations Secretary Marcelo Ebrard also announced that a team of five officials, including a general and a prison director, has been formed to implement the immigration plan.
Ebrard said that Gen. Vicente Antonio Hernández Sánchez, commander of the Tapachula military zone near the border with Guatemala, will begin a tour of the south “to speed up the deployment in the area.”
The main objective is to register migrants, offer them options for regularizing their immigration status and return those who don’t want to register, he added.
Ebrard did not mention detentions, which have risen notably in recent months, but said there is a need to expand and improve overcrowded immigration facilities that operate as de facto detention centers.
Another deployment is going to the frontier with the United States to attend to migrants who have been returned to Mexico while their asylum claims are processed in U.S. courts.
As part of the deal reached last Friday with Washington, Mexico agreed to an expansion of the program known as Migrant Protection Protocol, though the United States has run into its own logistical obstacles to ramping it up.
There have been more than 11,000 returns by migrants to Mexico under MPP since it launched in January, according to the most recent figures from the Mexican government.
Mexico’s National Guard is a newly formed force tasked with policing rising insecurity. It is separate from the military and is legally supposed to be under civilian command, though it is largely made up of current or former soldiers and federal police.
Scientists have recently developed advanced protocols harnessing the power of exosomes to create a new class of therapeutics to improve the effectiveness of stem cell therapy. In particular, they have developed new protocols for neurological diseases such as Alzheimer´s, Parkinson´s, Autism and Multiple Sclerosis. Read More